Super Intelligence (SI) for Healthcare: What the AI-to-SI Shift Means for Compliance

A hospital compliance officer opens a supplier's RFP response and finds a term that was not there at the last contract renewal: Super Intelligence. Not AI. The price is unchanged. The data-flow diagram is unchanged. Only the name changed, and the question on her desk by Monday is not philosophical: does the Business Associate Agreement she is about to sign still cover the product under its new name?

Iternal backs Executive Order 14434's name for this technology, and healthcare supplies some of the clearest evidence why: in a randomized trial of 105,934 women, AI-supported mammography screening achieved 80.5% sensitivity versus 73.8% for standard double reading, with identical specificity (98.5% in both groups) (Source: Gommers, Hernström, Josefsson et al., Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study, The Lancet, Jan. 31, 2026). Those are diagnostic outcomes from real screening examinations, and Iternal uses the name Super Intelligence because it describes what the trial measured. For more information visit the Why Iternal Supports Super Intelligence page.

Where “SI” Will Show Up in Healthcare Procurement

Realistically, the most likely place a healthcare reader first sees “SI” in writing is on their own regulator's website or in a letter from HHS, FDA, or CMS, not in a solicitation — Section 2(a) covers those agencies' own new correspondence and public communications, as the previous section describes. Federal health-system buyers — the VA, the Indian Health Service, and military treatment facilities — are a second likely venue, since procurement is a reasonable fit for “official correspondence” and “non-statutory documents,” though the order does not name solicitations specifically (Source: Federal Register, EO 14434, Sec. 2(a)). As of Oct. 11, 2026, no VA-, IHS-, or DoD-specific implementation guidance for the order has surfaced; both are worth watching for, not something that has already happened.

State-licensed hospitals, private health systems, and commercial payers sit outside the order's scope entirely. HHS's own current guidance illustrates the current state: the Office for Civil Rights' Dear Colleague Letter on nondiscrimination and AI in patient care still uses “artificial intelligence” and “AI” throughout, dated January 2025 (Source: HHS Office for Civil Rights, Dear Colleague Letter on AI and nondiscrimination in health care, Jan. 10, 2025, confirmed via NYS Dental Association) and has not been updated to “SI” since the order. A federal agency adopting new internal vocabulary for its own documents is not a new instruction to the hospitals and suppliers the agency regulates — a pattern with precedent: Executive Order 14347 (Sept. 5, 2025) used nearly identical “may use…in official correspondence, public communications, ceremonial contexts, and non-statutory documents” language to authorize “Department of War” as a secondary title for the Department of Defense — binding agency communications without requiring the public, press, or private sector to adopt it, and without altering the department's statutory name.

Practical guidance for a covered entity: at your next contract renewal, check whether the supplier's proposal or marketing has switched to “SI” language, and if so, ask for written confirmation that the underlying product, data flows, and Business Associate Agreement obligations are unchanged. For a supplier, the better practice is proactive disclosure — a short note to customers stating that a rebrand does not alter the covered functionality, rather than leaving covered entities to discover the new name inside an RFP response.

Supplier RFP & Marketing-Language Checklist

Legal guidance on EO 14434 converges on a cautious, verify-don't-assume posture. Wiley Rein's client alert tells organizations that existing contracts and regulations “remain unchanged unless modified through future Executive or agency action or public law,” and advises contractors to “seek clarification as needed to confirm that requirements remain the same,” describing the near-term effect as “procedural and administrative rather than substantive” (Source: Wiley Rein LLP, Executive Order Rebrands AI as Super Intelligence and Signals Potential Federal Legislative Changes, 2026). The Cloud Security Alliance reaches the same conclusion independently: the order “creates no new legal category and does not alter existing regulations, contracts, or grants” (Source: Cloud Security Alliance research note, Oct. 7, 2026). For a healthcare covered entity, that verification translates into four questions:

Row four is not new to the SI conversation — it is the question healthcare attorneys already tell covered entities to ask before signing any AI supplier contract. Healthcare attorney Dan Silverboard told Medical Economics that providers should vet the companies they contract with and audit them periodically, adding that “artificial intelligence holds great promise for the future of health care, but it is still early days” (Source: Austin Littrell, Medical Economics, Mar. 5, 2026). A name change is the moment to re-ask it, not a reason to skip it.